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Objectives: To date the focus of both development and application of HRQoL instru-
ments has been on research/clinical trials, but their application in clinical practice has 
been neglected. Therefore a PRO was conceptualized for use in clinical practice. The 
aim of this study was to explore the views of patients with haematological malignan-
cies (HM) concerning the quality of life issues important to them. MethOds: Ethics 
approval was obtained from Bristol Ethics Committee. Adult patients (with myeloid 
or lymphoid neoplasm or acute leukemia according to 2008 WHO classification at any 
stage of disease) capable of reading/understanding English and able to give informed 
written consent were recruited into the study. This qualitative study employed semi-
structured interviews (face-to-face or by phone) and survey (online) with open-ended 
questions for data collection. Interviews were tape recorded and transcribed verba-
tim. Content analysis was carried out using Nvivo9. Results: 57 patients (male= 37; 
female= 20) with mean age of 61.8 (sd= 9.1) and mean duration of disease of 3.7 
(sd= 3.1) were recruited into the study. 14 of the 17 interviews were face-to-face and 
remaining 40 were online surveys. Of the 57, 46 were multiple myeloma, 8 MDS, one 
NHL and 2 AML. Issues reported by patients were grouped into two broad categories: 
symptoms; and QoL. The symptoms were grouped into 5 categories: breathlessness; 
fractures; spinal problems; anaemia and black urine. 21 QoL issues were reported by 
patients with the highly prevalent items being ‘feeling angry’, ‘avoid crowds’, ‘strain on 
relationships’, ‘unable to do any activity’ and ‘doing things slowly’. These QoL issues 
appear to be unique to such patients. cOnclusiOns: The findings of this study 
indicate that there are certain symptoms and QoL issues that are specific to patients 
with HM and thus deserve a dedicated recognition. This also demonstrates the depth 
and breadth of the impact of HM on physical and psychosocial functional behavior.
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Objectives: The current value set for the German version of the EQ-5D-3L was gen-
erated more than 10 years ago and there is also a demand for a new valuation study, 
because the questionnaire has been changed from a 3-level to a 5-level version. The 
aim of this study was to derive a value set for the EQ-5D-5L for Germany. MethOds: 
The study design followed, as one of the first countries, the improved EQ-5D-5L valu-
ation protocol developed by the EuroQol Research Foundation. Data were collected in 
computer assisted personal interviews with members of the German general popula-
tion. Participants were asked to each value a randomly selected block of 10 EQ-5D-5L 
health states using composite time trade-off (cTTO). Econometric modelling was used 
to estimate values for all 3,125 possible health states described by the EQ-5D-5L. The 
most appropriate model was determined in terms of logical consistency, goodness 
of fit and parsimony. Results: The values for 86 selected EQ-5D-5L health states 
were elicited using cTTO from a representative general population sample (n= 1,159). 
Random effects model with main effects represented by 20 dummy variables and a 
constant performed better than the other models. This model showed high consist-
ency in the sense that the higher the dimensional level the lower the coefficient for 
all parameter estimates (p-value< 0.05). The predicted values ranged from -0.4675 to 
0.9876. cOnclusiOns: The improved valuation protocol combined with intensive 
interviewer training and close data monitoring showed a high feasibility and accept-
ability to respondents as well as interviewers in Germany and resulted in high data 
quality. The EQ-5D-5L preference values estimated in this study might facilitate the 
use of the EQ-5D-5L in a range of applications like in cost-utility analysis for health 
care policy and clinical assessment in Germany.
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Objectives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial designed to assess whether natalizumab slows disability progression in sec-
ondary progressive multiple sclerosis (SPMS). The objective of this study was to 
use Rasch Measurement Theory (RMT) methods to evaluate the Multiple Sclerosis 
Impact Scale (MSIS-29) and MS Walking Scale (MSWS-12), patient-reported out-
come instruments assessing the impact of MS, and to explore an optimized scor-
ing structure based on empirical post-hoc analyses. MethOds: Baseline blinded 
data from ASCEND (n= 889) were analyzed. In stage 1, RMT methods examined: 
scale-to-sample targeting, item fit, local dependency, and reliability. In stage 2, a 
post-hoc revision of the scoring structure (MSIS-29 and MSWS-12) and conceptual 
grouping of items (MSIS-29 only) was conducted and re-evaluated. Results: Stage 
1 showed adequate scale performance for the MSIS-29 except for item misfit (6 
Physical items; 2 Psychological items), suggesting more than two clinical concepts. 
The MSWS-12 performed psychometrically well except for disordered thresholds 
(2/12), item misfit (3/12) and mis-targeting (person location range: -5.01 to 5.77; item 
location range: -2.99 to 4.10). For stage 2, two MSWS-12 items were rescored. The 
revised MSWS-12 showed improved scale performance (i.e., response categories and 
item fit), but not targeting. The MSIS-29 was re-categorized into three conceptually 
clearer sub-scales: ‘Symptoms’; ‘Psychological’; ‘Limitations’. The revised MSIS-29 
scoring structure improved targeting and some item misfit (person location range; 
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Objectives: Existing evidence on the psychometric properties of physical func-
tioning and pain outcomes measures used in the chronic low back pain (CLBP) 
trials are not been systematically reviewed. The objective of our study was to 
evaluate the methodological quality of studies that evaluated psychometric prop-
erties of functioning and pain outcome measures for CLBP using Consensus-based 
Standards for the selection of health status Measurement Instruments (COSMIN) 
check list. MethOds: We searched Pubmed and EMBASE databases from inception 
to June 2015 with specific key words. Longitudinal cohort and cross sectional stud-
ies which included at least one assessment of psychometric property of outcomes 
measure in CLBP patients were included. Studies published in English language 
and on humans were included. Studies published as reviews, editorials and case 
reports were excluded. Two reviewers independently performed study selection, 
data extraction and quality assessment procedures; disagreements between 
reviewers were resolved through discussion. Results: A total of 32 studies met 
our inclusion criteria. In this systematic review only one third (34%) of instruments 
were tested for all psychometric properties and showed mixed methodological 
quality according to COSMIN check list. Among all instruments Quebec Back 
Pain Disability Scale had showed excellent reliability (Cronbach’s alpha coeffi-
cient 0.96) and test-retest reliability (ICC= 0.92) for physical functioning assess-
ment. Pain Catastrophising Scale had showed excellent reliability (α = 0.92) and 
high degree test-retest reliability (ICC= 0.842). More than half of the instruments 
showed excellent/good reliability and half showed fair validity. Responsiveness 
was assessed in only nine studies and had all showed fair quality. cOnclusiOns: 
Overall we found moderate methodological quality for most of the measures to 
advise tools use based on psychometric properties. Further research is needed to 
investigate the psychometric properties of all outcome measures used in CLBP 
research.
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Objectives: Although job-related stress has been reported to critically influence 
quality of life (QoL), few studies reported the optimum instruments to measure job-
related QoL. The aim of the study was to investigate the type and frequency of instru-
ment used to assesses the level of stress or quality of life related work. MethOds: A 
systemic search of PubMed was employed to find all relevant full texts for recent 5 
years focusing on human participants. Search keywords included “job-related stress 
or work-related stress”, and “Quality of life”. Information regarding the methods 
used to quantify stress, instruments used to measure quality of life, demographic 
and professional characteristics of the target population, as well as the sample size 
was gathered. Results: 50 studies were found during study period, of which 28 
of them examined the job related stress and the QoL. Of those 28 studies, health 
care workers were most frequently studied (19), and diverse methods were used 
to quantify the level of stress, of which JCQ (Karasek’s job content questionnaire), 
was most frequently used, followed by ERI(Siegrist’s Effort-Reward Imbalance) and 
JSS(Job Stress Scale). Frequently, however, stress level was not quantified at all 
(5 out of 28 studies). Regarding QoL instruments, SF-12/36 were most frequently 
used (11 studies), followed by PROQoL(The Professional Quality of Life Scale) and 
WHOQoL(The World Health Organization Quality of Life)., yet few studies provided 
explanation regarding the selection of the methods used. cOnclusiOns: Diverse 
methods have been used to evaluate the impact of job-related stress on the QoL, 
without proper justification. Methodologically robust studies could enhance the 
importance of job-related stress on the QoL.
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Objectives: To compare two methods for estimation of Work Limitations 
Questionnaire scores (WLQ, 8 items) from the Role Physical (RP, 4 items) and Role 
Emotional scales (RE, 3 items) of the SF-36 Health survey. These measures assess 
limitations in role performance attributed to health (emotional, physical, or both) 
and different breadth of impact (work vs. work and other activities). We compared 
WLQ estimates based on an item response theory crosswalk (Method1) and a regres-
sion imputation (Method 2). Such estimates can expand the information from 
studies using only the SF-36 measure, and can inform future data collection strate-
gies. MethOds: We used data from two independent cross-sectional panel samples 
(Sample1, n= 1382, 51% female, 72% Caucasian, 49% with preselected chronic condi-
tions, 15% with fair/poor health; Sample2, n= 301, 45% female, 90% Caucasian, 47% 
with preselected chronic conditions, 21% with fair/poor health). Method 1 used previ-
ously developed and validated IRT based calibration tables. Method 2 used regression 
models to develop aggregate imputation weights as described in the literature. We 
evaluated the agreement of observed and estimated WLQ scale scores from the two 
methods and their ability to discriminate among known groups of patients. Results: 
Estimated scores from the two methods were strongly correlated (r= .99). Estimated 
and observed scale scores had strong correlations (r= .68 for RE and r= .76 for RP). 
Observed and estimated WLQ from both methods successfully differentiated between 
levels of self reported general health and between patients with and without chronic 
conditions. For both methods the estimated WLQ means from SF36RP score were 
closer (and not statistically different for Method1) to the observed WLQ means than 
estimated WLQ scores from the SF36 RE scale. cOnclusiOns: Our results suggest 
that both methods provide useful WLQ estimates for group level analysis. Method 1 
appears slightly more accurate than Method 2, but is computationally more complex.
